577
Views
20
CrossRef citations to date
0
Altmetric
Reviews

Controlled Adverse Environment Chambers in Dry Eye Research

ORCID Icon, , , , , ORCID Icon, , , , , & show all
Pages 445-450 | Received 16 Jun 2017, Accepted 18 Dec 2017, Published online: 16 Jan 2018

References

  • Stern ME, Beuerman RW, Fox RI, Gao J, Mircheff AK, Pflugfelder SC. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea. 1998;17:584–89.
  • Lemp MA, Baudouin C, Baum J, Dogru M, Foulks GN, Kinoshita S, et al. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop. Ocul Surf. 2007;5:75–92.
  • Stern ME, Gao J, Siemasko KF, Beuerman RW, Pflugfelder SC. The role of the lacrimal functional unit in the pathophysiology of dry eye. Exp Eye Res. 2004;78:409–16.
  • Tesón M, González-García MJ, López-Miguel A, Enríquez-de-Salamanca A, Martín-Montañez V, Benito MJ, et al. Influence of a controlled environment simulating an in-flight airplane cabin on dry eye disease. Invest Ophthalmol Vis Sci. 2013;54:2093–99.
  • Bekö G, Allen JG, Weschler CJ, Vallarino J, Spengler JD. Impact of cabin ozone concentrations on passenger reported symptoms in commercial aircraft. PLoS One. 2015;10:e0128454.
  • Galor A, Kumar N, Feuer W, Lee DJ. Environmental factors affect the risk of dry eye syndrome in a United States veteran population. Ophthalmology. 2014;121:972–73.
  • Hwang SH, Choi YH, Paik HJ, Wee WR, Kim MK, Kim DH. Potential importance of ozone in the association between outdoor air pollution and dry eye disease in South Korea. JAMA Ophthalmol. 2016. doi:10.1001/jamaophthalmol.2016.0139. [ Epub ahead of print].
  • Jie Y, Xu L, Wu YY, Jonas JB. Prevalence of dry eye among adult Chinese in the Beijing Eye Study. Eye (Lond). 2009;23:688–93.
  • Novaes P, Saldiva PH, Matsuda M, Macchione M, Rangel MP, Kara-José N, et al. The effects of chronic exposure to traffic derived air pollution on the ocular surface. Environ Res. 2010;110:372–74.
  • Gupta SK, Gupta V, Joshi S, Tandon R. Subclinically dry eyes in urban Delhi: an impact of air pollution? Ophthalmologica. 2002;216:368–71.
  • Bourcier T, Viboud C, Cohen JC, Thomas F, Bury T, Cadiot L, et al. Effects of air pollution and climatic conditions on the frequency of ophthalmological emergency examinations. Br J Ophthalmol. 2003;87:809–11.
  • López-Miguel A, Tesón M, Martín-Montañez V, Enríquez-de-Salamanca A, Stern ME, Calonge M, et al. Dry eye exacerbation in patients exposed to desiccating stress under controlled environmental conditions. Am J Ophthalmol. 2014;157:788–798.e2.
  • González-García MJ, González-Sáiz A, De La Fuente B, Morilla-Grasa A, Mayo-Iscar A, San-José J, et al. Exposure to a controlled adverse environment impairs the ocular surface of subjects with minimally symptomatic dry eye. Invest Ophthalmol Vis Sci. 2007;48:4026–32.
  • Martín-Montañez V, Enríquez-de-Salamanca A, López-De La Rosa A, López-Miguel A, Fernández I, Calonge M, et al. Effect of environmental conditions on the concentration of tear inflammatory mediators during contact lens wear. Cornea. 2016;35:1192–98.
  • Van Setten G, Labetoulle M, Baudouin C, Rolando M. Evidence of seasonality and effects of psychrometry in dry eye disease. Acta Ophthalmol. 2016;94:499–506.
  • Ward SK, Dogru M, Wakamatsu T, Ibrahim O, Matsumoto Y, Kojima T, et al. Passive cigarette smoke exposure and soft contact lens wear. Optom Vis Sci. 2010;87:367–72.
  • Lois N, Abdelkader E, Reglitz K, Garden C, Ayres JG. Environmental tobacco smoke exposure and eye disease. Br J Ophthalmol. 2008;92:1304–10.
  • Milner MS, Beckman KA, Luchs JI, Allen QB, Awdeh RM, Berdahl J, et al. Dysfunctional tear syndrome: dry eye disease and associated tear film disorders—new strategies for diagnosis and treatment. Curr Opin Ophthalmol. 2017;28(Suppl1):3–47.
  • Bartlett JD, Keith MS, Sudharshan L, Snedecor SJ. Associations between signs and symptoms of dry eye disease: a systematic review. Clin Ophthalmol. 2015;9:1719–30.
  • Cuevas M, González-García MJ, Castellanos E, Quispaya R, Parra Pde L, Fernández I, et al. Correlations among symptoms, signs, and clinical tests in evaporative-type dry eye disease caused by Meibomian gland dysfunction (MGD). Curr Eye Res. 2012;37:855–63.
  • Ousler GW, Gomes PJ, Welch D, Abelson MB. Methodologies for the study of ocular surface disease. Ocul Surf. 2005;3:143–54.
  • Barabino S, Shen L, Chen L, Rashid S, Rolando M, Dana MR. The controlled-environment chamber: a new mouse model of dry eye. Invest Ophthalmol Vis Sci. 2005;46:2766–71.
  • Dursun D, Wang M, Monroy D, Li DQ, Lokeshwar BL, Stern ME, et al. A mouse model of keratoconjunctivitis sicca. Invest Ophthalmol Vis Sci. 2002;43:632–38.
  • Chen W, Zhang X, Li J, Wang Y, Chen Q, Hou C, et al. Efficacy of osmoprotectants on prevention and treatment of murine dry eye. Invest Ophthalmol Vis Sci. 2013;54:6287–97.
  • López-Miguel A, Tesón M, Martín-Montañez V, Enríquez-de-Salamanca A, Stern ME, González-García MJ, et al. Clinical and molecular inflammatory response in Sjögren syndrome-associated dry eye patients under desiccating stress. Am J Ophthalmol. 2016;161:133–141.e1–2.
  • Kojima T, Matsumoto Y, Ibrahim OM, Wakamatsu TH, Uchino M, Fukagawa K, et al. Effect of controlled adverse chamber environment exposure on tear functions in silicon hydrogel and hydrogel soft contact lens wearers. Invest Ophthalmol Vis Sci. 2011;52:8811–17.
  • Tomlinson A, Madden LC, Simmons PA. Effectiveness of dry eye therapy under conditions of environmental stress. Curr Eye Res. 2013;38:229–36.
  • Madden LC, Tomlinson A, Simmons PA. Effect of humidity variations in a controlled environment chamber on tear evaporation after dry eye therapy. Eye Contact Lens. 2013;39:169–74.
  • Petrov A, Perekhvatova N, Skulachev M, Stein L, Ousler G. SkQ1 ophthalmic solution for dry eye treatment: results of a phase 2 safety and efficacy clinical study in the environment and during challenge in the controlled adverse environment model. Adv Ther. 2016;33:96–115.
  • Abusharha AA, Pearce EI. The effect of low humidity on the human tear film. Cornea. 2013;32:429–34.
  • Alex A, Edwards A, Hays JD, Kerkstra M, Shih A, De Paiva CS, et al. Factors predicting the ocular surface response to desiccating environmental stress. Invest Ophthalmol Vis Sci. 2013;54:3325–32.
  • Barabino S, Dana MR. Animal models of dry eye: a critical assessment of opportunities and limitations. Invest Ophthalmol Vis Sci. 2004;45:1641–46.
  • Barabino S, Antonelli S, Cimbolini N, Mauro V, Bouzin M. The effect of preservatives and antiglaucoma treatments on the ocular surface of mice with dry eye. Invest Ophthalmol Vis Sci. 2014;55:6499–504.
  • Rashid S, Jin Y, Ecoiffier T, Barabino S, Schaumberg DA, Dana MR. Topical omega-3 and omega-6 fatty acids for treatment of dry eye. Arch Ophthalmol. 2008;126:219–25.
  • Fabiani C, Barabino S, Rashid S, Dana MR. Corneal epithelial proliferation and thickness in a mouse model of dry eye. Exp Eye Res. 2009;89:166–71.
  • Sosne G, Kim C, Kleinman HK. Thymosin β4 significantly reduces the signs of dryness in a murine controlled adverse environment model of experimental dry eye. Expert Opin Biol Ther. 2015;15(Suppl 1):S155–S161.
  • Cocho L, Fernández I, Calonge M, Martínez V, González-García MJ, Caballero D, et al. Gene expression-based predictive models of graft versus host disease-associated dry eye. Invest Ophthalmol Vis Sci. 2015;56:4570–81.
  • Cocho L, Fernández I, Calonge M, Martínez V, González-García MJ, Caballero D, et al. Biomarkers in ocular chronic graft versus host disease: tear cytokine- and chemokine-based predictive model. Invest Ophthalmol Vis Sci. 2016;57:746–58.
  • Bron AJ, Tomlinson A, Foulks GN, Pepose JS, Baudouin C, Geerling G, et al. Rethinking dry eye disease: a perspective on clinical implications. Ocul Surf. 2014;12(2 Suppl):S1–S31.
  • Uchino M, Nishiwaki Y, Michikawa T, Shirakawa K, Kuwahara E, Yamada M, et al. Prevalence and risk factors of dry eye disease in Japan: koumi study. Ophthalmology. 2011;118:2361–67.
  • Doughty MJ, Fonn D, Richter D, Simpson T, Caffery B, Gordon K. A patient questionnaire approach to estimating the prevalence of dry eye symptoms in patients presenting to optometric practices across Canada. Optom Vis Sci. 1997;74:624–31.
  • Chalmers RL, Begley CG. Dryness symptoms among an unselected clinical population with and without contact lens wear. Contact Lens Anter Eye. 2006;29:25–30.
  • Uchino M, Dogru M, Uchino Y, Fukagawa K, Shimmura S, Takebayashi T, et al. Japan Ministry of Health study on prevalence of dry eye disease among Japanese high school students. Am J Ophthalmol. 2008;146:925–29.
  • Begley CG, Chalmers RL, Mitchell GL, Nichols KK, Caffery B, Simpson T, et al. Characterization of ocular surface symptoms from optometric practices in North America. Cornea. 2001;20:610–18.
  • Richdale K, Sinnott LT, Skadahl E, Nichols JJ. Frequency of and factors associated with contact lens dissatisfaction and discontinuation. Cornea. 2007;26:168–74.
  • Martín-Montañez V, López-Miguel A, Arroyo C, Mateo ME, González-Méijome JM, Calonge M, et al. Influence of environmental factors in the in vitro dehydration of hydrogel and silicone hydrogel contact lenses. J Biomed Mater Res B Appl Biomater. 2014;102:764–71.
  • Meerovitch K, Torkildsen G, Lonsdale J, Goldfarb H, Lama T, Cumberlidge G, et al. Safety and efficacy of MIM-D3 ophthalmic solutions in a randomized, placebo-controlled phase 2 clinical trial in patients with dry eye. Clin Ophthalmol. 2013;7:1275–85.
  • Pinto-Fraga J, López-Miguel A, González-García MJ, Fernández I, López-de-la-Rosa A, Enríquez-de-Salamanca A, et al. Topical fluorometholone protects the ocular surface of dry eye patients from desiccating stress: a randomized controlled clinical trial. Ophthalmology. 2016;123:141–53.
  • Moore QL, De Paiva CS, Pflugfelder SC. Effects of dry eye therapies on environmentally induced ocular surface disease. Am J Ophthalmol. 2015;160:135–42.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.